Effects of pomegranate juice on blood pressure: A systematic review and meta-analysis of randomized controlled trials

Amirhossein Sahebkar, Claudio Ferri, Paolo Giorgini, Simona Bo, Petr Nachtigal, Davide Grassi

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Punica granatum L. (Pomegranate) has been claimed to provide several health benefits. Pomegranate juice is a polyphenol-rich fruit juice with high antioxidant capacity. Several studies suggested that pomegranate juice can exert antiatherogenic, antioxidant, antihypertensive, and anti-inflammatory effects. Nevertheless, the potential cardioprotective benefits of pomegranate juice deserve further clinical investigation. To systematically review and meta-analyze available evidence from randomized placebo-controlled trials (RCTs) investigating the effects of pomegranate juice consumption and blood pressure (BP). A comprehensive literature search in Medline and Scopus was carried out to identify eligible RCTs. A meta-analysis of eligible studies was performed using a random-effects model. Quality assessment, sensitivity analysisand publication bias evaluations were conducted using standard methods. Quantitative data synthesis from 8 RCTs showed significant reductions in both systolic [weighed mean difference (WMD): −4.96 mmHg, 95% CI: −7.67 to −2.25, p < 0.001) and diastolic BP (WMD: −2.01 mmHg, 95% CI: −3.71 to −0.31, p = 0.021) after pomegranate juice consumption. Effects on SBP remained stable to sensitivity analyses. Pomegranate juice reduced SBP regardless of the duration (>12 wks: WMD = −4.36 mmHg, 95% CI: −7.89 to −0.82, p = 0.016) and <12 wks: WMD = −5.83 mmHg, 95% CI: −10.05 to −1.61, p = 0.007) and dose consumed (>240 cc: WMD = −3.62 mmHg, 95% CI: −6.62 to −0.63, p = 0.018) and <240 cc: WMD = −11.01 mmHg, 95% CI: −17.38 to −4.65, p = 0.001, pomegranate juice per day) whereas doses >240 cc provided a borderline significant effect in reducing DBP. The present meta-analysis suggests consistent benefits of pomegranate juice consumption on BP. This evidence suggests it may be prudent to include this fruit juice in a heart-healthy diet.

Original languageEnglish
Pages (from-to)149-161
Number of pages13
JournalPharmacological Research
Volume115
DOIs
Publication statusPublished - 1 Jan 2017

Fingerprint

Punicaceae
Meta-Analysis
Randomized Controlled Trials
Blood Pressure
Placebos
Antioxidants
Publication Bias
Polyphenols
Insurance Benefits
Antihypertensive Agents
Anti-Inflammatory Agents

Cite this

Sahebkar, Amirhossein ; Ferri, Claudio ; Giorgini, Paolo ; Bo, Simona ; Nachtigal, Petr ; Grassi, Davide. / Effects of pomegranate juice on blood pressure : A systematic review and meta-analysis of randomized controlled trials. In: Pharmacological Research. 2017 ; Vol. 115. pp. 149-161.
@article{d42ad8c1750340848b0d107562ca2697,
title = "Effects of pomegranate juice on blood pressure: A systematic review and meta-analysis of randomized controlled trials",
abstract = "Punica granatum L. (Pomegranate) has been claimed to provide several health benefits. Pomegranate juice is a polyphenol-rich fruit juice with high antioxidant capacity. Several studies suggested that pomegranate juice can exert antiatherogenic, antioxidant, antihypertensive, and anti-inflammatory effects. Nevertheless, the potential cardioprotective benefits of pomegranate juice deserve further clinical investigation. To systematically review and meta-analyze available evidence from randomized placebo-controlled trials (RCTs) investigating the effects of pomegranate juice consumption and blood pressure (BP). A comprehensive literature search in Medline and Scopus was carried out to identify eligible RCTs. A meta-analysis of eligible studies was performed using a random-effects model. Quality assessment, sensitivity analysisand publication bias evaluations were conducted using standard methods. Quantitative data synthesis from 8 RCTs showed significant reductions in both systolic [weighed mean difference (WMD): −4.96 mmHg, 95{\%} CI: −7.67 to −2.25, p < 0.001) and diastolic BP (WMD: −2.01 mmHg, 95{\%} CI: −3.71 to −0.31, p = 0.021) after pomegranate juice consumption. Effects on SBP remained stable to sensitivity analyses. Pomegranate juice reduced SBP regardless of the duration (>12 wks: WMD = −4.36 mmHg, 95{\%} CI: −7.89 to −0.82, p = 0.016) and <12 wks: WMD = −5.83 mmHg, 95{\%} CI: −10.05 to −1.61, p = 0.007) and dose consumed (>240 cc: WMD = −3.62 mmHg, 95{\%} CI: −6.62 to −0.63, p = 0.018) and <240 cc: WMD = −11.01 mmHg, 95{\%} CI: −17.38 to −4.65, p = 0.001, pomegranate juice per day) whereas doses >240 cc provided a borderline significant effect in reducing DBP. The present meta-analysis suggests consistent benefits of pomegranate juice consumption on BP. This evidence suggests it may be prudent to include this fruit juice in a heart-healthy diet.",
keywords = "Antioxidants, Blood pressure, Cardiovascular risk, Flavonoids, Pomegranate",
author = "Amirhossein Sahebkar and Claudio Ferri and Paolo Giorgini and Simona Bo and Petr Nachtigal and Davide Grassi",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.phrs.2016.11.018",
language = "English",
volume = "115",
pages = "149--161",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press",

}

Effects of pomegranate juice on blood pressure : A systematic review and meta-analysis of randomized controlled trials. / Sahebkar, Amirhossein; Ferri, Claudio; Giorgini, Paolo; Bo, Simona; Nachtigal, Petr; Grassi, Davide.

In: Pharmacological Research, Vol. 115, 01.01.2017, p. 149-161.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of pomegranate juice on blood pressure

T2 - A systematic review and meta-analysis of randomized controlled trials

AU - Sahebkar, Amirhossein

AU - Ferri, Claudio

AU - Giorgini, Paolo

AU - Bo, Simona

AU - Nachtigal, Petr

AU - Grassi, Davide

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Punica granatum L. (Pomegranate) has been claimed to provide several health benefits. Pomegranate juice is a polyphenol-rich fruit juice with high antioxidant capacity. Several studies suggested that pomegranate juice can exert antiatherogenic, antioxidant, antihypertensive, and anti-inflammatory effects. Nevertheless, the potential cardioprotective benefits of pomegranate juice deserve further clinical investigation. To systematically review and meta-analyze available evidence from randomized placebo-controlled trials (RCTs) investigating the effects of pomegranate juice consumption and blood pressure (BP). A comprehensive literature search in Medline and Scopus was carried out to identify eligible RCTs. A meta-analysis of eligible studies was performed using a random-effects model. Quality assessment, sensitivity analysisand publication bias evaluations were conducted using standard methods. Quantitative data synthesis from 8 RCTs showed significant reductions in both systolic [weighed mean difference (WMD): −4.96 mmHg, 95% CI: −7.67 to −2.25, p < 0.001) and diastolic BP (WMD: −2.01 mmHg, 95% CI: −3.71 to −0.31, p = 0.021) after pomegranate juice consumption. Effects on SBP remained stable to sensitivity analyses. Pomegranate juice reduced SBP regardless of the duration (>12 wks: WMD = −4.36 mmHg, 95% CI: −7.89 to −0.82, p = 0.016) and <12 wks: WMD = −5.83 mmHg, 95% CI: −10.05 to −1.61, p = 0.007) and dose consumed (>240 cc: WMD = −3.62 mmHg, 95% CI: −6.62 to −0.63, p = 0.018) and <240 cc: WMD = −11.01 mmHg, 95% CI: −17.38 to −4.65, p = 0.001, pomegranate juice per day) whereas doses >240 cc provided a borderline significant effect in reducing DBP. The present meta-analysis suggests consistent benefits of pomegranate juice consumption on BP. This evidence suggests it may be prudent to include this fruit juice in a heart-healthy diet.

AB - Punica granatum L. (Pomegranate) has been claimed to provide several health benefits. Pomegranate juice is a polyphenol-rich fruit juice with high antioxidant capacity. Several studies suggested that pomegranate juice can exert antiatherogenic, antioxidant, antihypertensive, and anti-inflammatory effects. Nevertheless, the potential cardioprotective benefits of pomegranate juice deserve further clinical investigation. To systematically review and meta-analyze available evidence from randomized placebo-controlled trials (RCTs) investigating the effects of pomegranate juice consumption and blood pressure (BP). A comprehensive literature search in Medline and Scopus was carried out to identify eligible RCTs. A meta-analysis of eligible studies was performed using a random-effects model. Quality assessment, sensitivity analysisand publication bias evaluations were conducted using standard methods. Quantitative data synthesis from 8 RCTs showed significant reductions in both systolic [weighed mean difference (WMD): −4.96 mmHg, 95% CI: −7.67 to −2.25, p < 0.001) and diastolic BP (WMD: −2.01 mmHg, 95% CI: −3.71 to −0.31, p = 0.021) after pomegranate juice consumption. Effects on SBP remained stable to sensitivity analyses. Pomegranate juice reduced SBP regardless of the duration (>12 wks: WMD = −4.36 mmHg, 95% CI: −7.89 to −0.82, p = 0.016) and <12 wks: WMD = −5.83 mmHg, 95% CI: −10.05 to −1.61, p = 0.007) and dose consumed (>240 cc: WMD = −3.62 mmHg, 95% CI: −6.62 to −0.63, p = 0.018) and <240 cc: WMD = −11.01 mmHg, 95% CI: −17.38 to −4.65, p = 0.001, pomegranate juice per day) whereas doses >240 cc provided a borderline significant effect in reducing DBP. The present meta-analysis suggests consistent benefits of pomegranate juice consumption on BP. This evidence suggests it may be prudent to include this fruit juice in a heart-healthy diet.

KW - Antioxidants

KW - Blood pressure

KW - Cardiovascular risk

KW - Flavonoids

KW - Pomegranate

UR - http://www.scopus.com/inward/record.url?scp=84999188049&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2016.11.018

DO - 10.1016/j.phrs.2016.11.018

M3 - Article

VL - 115

SP - 149

EP - 161

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

ER -